Moorfields Eye Hospital
About Moorfields Eye Hospital
Moorfields Eye Hospital is a specialist NHS eye hospital in Finsbury in the London Borough of Islington in London, England run by Moorfields Eye Hospital NHS Foundation Trust.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Moorfields Eye Hospital
During the past decade, Moorfields Eye Hospital conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 28 clinical trials were completed, i.e. on
average, 27.2% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 17 clinical trials were completed. i.e. 48.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
2015-11-06
2029-01-01
Recruiting
126
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
2017-01-13
2023-10-31
Active, not recruiting
818
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-05-12
2023-06-30
Active, not recruiting
444
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
2017-09-29
2022-04-15
Terminated
23
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
2017-12-22
2023-08-01
Active, not recruiting
1,670
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
2017-06-01
2024-08-01
Suspended
310
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
2017-04-13
2023-11-30
Suspended
175
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Moorfields Eye Hospital" #1 sponsor was "Moorfields Eye Hospital NHS Foundation Trust" with 31 trials, followed by "MeiraGTx UK II Ltd" with 12 trials
sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "University College, London" with 8 trials sponsored and "Boehringer Ingelheim"
with 8 trials sponsored. Other sponsors include 73 different institutions and
companies that sponsored additional 56 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Moorfields Eye Hospital"
#1 collaborator was "Moorfields Eye Hospital NHS Foundation Trust" with 13 trials as a collaborator, "University College, London" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator, "Janssen Research & Development, LLC" with 4 trials as a collaborator and "City, University of London" with 3 trials as a collaborator. Other collaborators include 102 different institutions and companies that were
collaborators in the rest 96 trials.
Clinical Trials Conditions at Moorfields Eye Hospital
According to Clinical.Site data, the most researched conditions in "Moorfields Eye Hospital" are
"Diabetic Retinopathy" (11 trials), "Diabetic Macular Edema" (10 trials), "Eye Diseases" (8 trials), "Uveitis" (8 trials) and "Retinitis Pigmentosa" (7 trials). Many other conditions were trialed in "Moorfields Eye Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Moorfields Eye Hospital
Most popular intervention types in "Moorfields Eye Hospital" are "Drug" (63 trials), "Other" (28 trials), "Device" (27 trials), "Biological" (18 trials) and "Procedure" (18 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Sham Procedure" (8 trials), "Ranibizumab" (6 trials), "Sham" (5 trials) and "Aflibercept" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Moorfields Eye Hospital
The vast majority of trials in "Moorfields Eye Hospital" are
141 trials for "All" genders and 4 trials for "Male" genders.
Clinical Trials Status at Moorfields Eye Hospital
Currently, there are 57 active trials in "Moorfields Eye Hospital".
3 are not yet recruiting,
29 are recruiting,
23 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 73 completed trials in Moorfields Eye Hospital,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Moorfields Eye Hospital, 22 "Phase 1"
clinical trials were conducted, 40 "Phase 2" clinical
trials and 38 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 7 trials, and there were
also 21 trials that are defined as “Not Applicable".